Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Sanofi-aventis acquires BMP Sunstone
BMP Sunstone stockholders will now receive $10 per share in cash for common stock shares they owned prior to the effective time of the merger. Beijing-based BMP Sunstone,
BMP Sunstone stockholders will now receive $10 per share in cash for common stock shares they owned prior to the effective time of the merger. Beijing-based BMP Sunstone,
Martek is involved in the innovation, development, production and sale of high-value products from microbial sources which promote health and wellness through nutrition. The transaction is part of
Under the pact, Selcia has used its proprietary CEfrag technique and has identified new and weak affinity hits from Selcia’s Fragment Library. Selcia claims that its CEfrag technology
The new film-forming polymer equips formulators with the know-how to manufacture hair sprays with firm and lasting hold. The hair styles secured by the new dispersion spray retain
Chinese herbal medicine business is engaged in the research and development, production and distribution of Chinese herbal medicines in China and overseas Following the transaction, the Chinese Herbal
Edarbi is an angiotensin II receptor blocker (ARB) that lowers blood pressure by blocking the action of angiotensin II, a vasopressor hormone. Results from clinical studies revealed that
Ganetespib is a potent, synthetic, small-molecule inhibitor of heat shock protein 90 – a molecular chaperone required for the proper folding and activation of many cancer-promoting proteins. The
Quintiles will make a minority 10% investment of about $30m in setting up a manufacturing plant (which will contract-make medicines derived from living cells) in the Songdo district
Taliglucerase alfa is a plant-cell expressed form of the enzyme glucocerebrosidase (GCD). Taliglucerase is the first product for Protalix, and works by replacing an enzyme missing in people
The move comes as a part of Fujifilm’s strategy of expanding into drug development given that the demand for supplying biologics is expected to increase by 15% a